Skip to content
Menu

BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $115

Benzinga Newsdesk 2 weeks ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $115.

BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $115.

Read at benzinga.com